Top Officials Acknowledge Difficulties Of Psychedelics Research In The U.S.
During an event organized by the National Academies of Sciences, Engineering and Medicine, titled “Exploring Psychedelics & Entactogens to Treat Psychiatric Disorders,” two officials noted the challenges scientists face in conducting research into Schedule I substances such as psychedelics,
